Columbia University BioWorks

BioWorks 8: AI-Driven Drug Discovery with Alex Zhavoronkov


Listen Later

In which Alex Zhavoronkov, founder and CEO of Insilico Medicine, discusses how AI can accelerate drug R&D, from target identification to clinical trials. He also shares his own path from computer science to biotech, explains how Insilico’s business model has evolved, and gives advice on leading interdisciplinary teams.

...more
View all episodesView all episodes
Download on the App Store

Columbia University BioWorksBy Columbia University Systems Biology Initiative